Vivace Therapeutics Announces Issuance of New U.S. Composition of Matter Patents

/PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway,...

Related Keywords

China ,United States ,Wuxi ,Jiangsu ,Tim Brons ,Trademark Office ,Vivace Therapeutics Inc ,Prnewswire Vivace Therapeutics Inc ,United States Patent ,Sofie Qiao ,Vivace Therapeutics ,San Francisco Bay Area ,Canaan Partners ,Wuxi Healthcare Ventures ,Cenova Capital ,Sequoia Capital China ,Boxer Capital ,Strategic Partners ,Nc ,